Meredith A. Collins

2.1k total citations · 1 hit paper
16 papers, 1.5k citations indexed

About

Meredith A. Collins is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Meredith A. Collins has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Meredith A. Collins's work include Pancreatic and Hepatic Oncology Research (12 papers), Cancer Cells and Metastasis (6 papers) and Phagocytosis and Immune Regulation (3 papers). Meredith A. Collins is often cited by papers focused on Pancreatic and Hepatic Oncology Research (12 papers), Cancer Cells and Metastasis (6 papers) and Phagocytosis and Immune Regulation (3 papers). Meredith A. Collins collaborates with scholars based in United States, Slovakia and China. Meredith A. Collins's co-authors include Marina Pasca di Magliano, Yaqing Zhang, Filip Bednar, Sabita Rakshit, Jean‐Christophe Brisset, Craig J. Galbán, Stefanie Galbán, Volkan Adsay, Wei Yan and Judith S. Sebolt–Leopold and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Genes & Development.

In The Last Decade

Meredith A. Collins

15 papers receiving 1.5k citations

Hit Papers

Oncogenic Kras is required for both the initiation and ma... 2012 2026 2016 2021 2012 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meredith A. Collins United States 12 1.0k 750 371 316 284 16 1.5k
Elisabeth Heßmann Germany 17 750 0.7× 773 1.0× 305 0.8× 203 0.6× 153 0.5× 39 1.3k
Evangeline Mose United States 18 551 0.5× 563 0.8× 239 0.6× 283 0.9× 154 0.5× 25 1.2k
Surabhi Dangi‐Garimella United States 14 673 0.6× 749 1.0× 426 1.1× 200 0.6× 146 0.5× 34 1.4k
Hayato Fujita Japan 21 783 0.7× 857 1.1× 719 1.9× 151 0.5× 242 0.9× 36 1.5k
Huocong Huang United States 18 803 0.8× 493 0.7× 254 0.7× 464 1.5× 100 0.4× 33 1.3k
Wanglong Qiu United States 21 841 0.8× 672 0.9× 318 0.9× 151 0.5× 319 1.1× 32 1.4k
Dannielle D. Engle United States 12 766 0.7× 561 0.7× 270 0.7× 377 1.2× 73 0.3× 19 1.2k
Lauren Marquis United States 4 674 0.6× 659 0.9× 322 0.9× 84 0.3× 219 0.8× 4 1.1k
Mehri Mollaee United States 10 781 0.7× 569 0.8× 535 1.4× 165 0.5× 114 0.4× 18 1.1k
Ivane Abiatari Georgia 13 512 0.5× 460 0.6× 214 0.6× 146 0.5× 164 0.6× 32 1.0k

Countries citing papers authored by Meredith A. Collins

Since Specialization
Citations

This map shows the geographic impact of Meredith A. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith A. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith A. Collins more than expected).

Fields of papers citing papers by Meredith A. Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meredith A. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith A. Collins. The network helps show where Meredith A. Collins may publish in the future.

Co-authorship network of co-authors of Meredith A. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Meredith A. Collins. A scholar is included among the top collaborators of Meredith A. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meredith A. Collins. Meredith A. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Takano, Shigetsugu, Maximilian Reichert, Basil Bakir, et al.. (2016). Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization. Genes & Development. 30(2). 233–247. 84 indexed citations
3.
Zhang, Yaqing, Kevin T. Kane, Meredith A. Collins, et al.. (2015). CD44 Regulates Pancreatic Cancer Invasion through MT1-MMP. Molecular Cancer Research. 13(1). 9–15. 71 indexed citations
4.
Bednar, Filip, Heather Schofield, Meredith A. Collins, et al.. (2015). Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism. Carcinogenesis. 36(7). 730–738. 21 indexed citations
5.
Abravanel, Daniel L., George K. Belka, Tien-Chi Pan, et al.. (2015). Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy. Journal of Clinical Investigation. 125(6). 2484–2496. 103 indexed citations
6.
Zhang, Yaqing, Wei Yan, Esha Mathew, et al.. (2015). Abstract PR11: CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice. Cancer Research. 75(13_Supplement). PR11–PR11. 4 indexed citations
7.
Zhang, Yaqing, Wei Yan, Esha Mathew, et al.. (2014). CD4+ T Lymphocyte Ablation Prevents Pancreatic Carcinogenesis in Mice. Cancer Immunology Research. 2(5). 423–435. 69 indexed citations
8.
Mathew, Esha, Meredith A. Collins, Maite G. Fernández‐Barrena, et al.. (2014). The Transcription Factor GLI1 Modulates the Inflammatory Response during Pancreatic Tissue Remodeling. Journal of Biological Chemistry. 289(40). 27727–27743. 38 indexed citations
9.
Collins, Meredith A. & Marina Pasca di Magliano. (2014). Kras as a key oncogene and therapeutic target in pancreatic cancer. Frontiers in Physiology. 4. 407–407. 96 indexed citations
10.
Zhang, Yaqing, Wei Yan, Filip Bednar, et al.. (2014). Abstract IA12: Oncogenic KRAS and the inflammatory microenvironment in pancreatic cancer. Molecular Cancer Research. 12(12_Supplement). IA12–IA12. 1 indexed citations
11.
Zhang, Yaqing, Wei Yan, Meredith A. Collins, et al.. (2013). Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance. Cancer Research. 73(20). 6359–6374. 197 indexed citations
12.
Collins, Meredith A., Wei Yan, Judith S. Sebolt–Leopold, & Marina Pasca di Magliano. (2013). MAPK Signaling Is Required for Dedifferentiation of Acinar Cells and Development of Pancreatic Intraepithelial Neoplasia in Mice. Gastroenterology. 146(3). 822–834.e7. 91 indexed citations
13.
Collins, Meredith A., Filip Bednar, Yaqing Zhang, et al.. (2012). Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. Journal of Clinical Investigation. 122(2). 639–653. 550 indexed citations breakdown →
14.
Collins, Meredith A., Jean‐Christophe Brisset, Yaqing Zhang, et al.. (2012). Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice. PLoS ONE. 7(12). e49707–e49707. 134 indexed citations
15.
Husein, Omar F., Meredith A. Collins, & D. Richard Kang. (2008). Neuroglial heterotopia causing neonatal airway obstruction: presentation, management, and literature review. European Journal of Pediatrics. 167(12). 1351–1355. 22 indexed citations
16.
Padma, M.V., et al.. (2001). 11C-methionine PET Imaging of Leptomeningeal Metastases from Primary Breast Cancer – a Case Report. Journal of Neuro-Oncology. 55(1). 39–44. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026